Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATBPF | AMGN | GILD | VRTX | BIIB |
| Company | Antibe Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2328 | 339.00 | 84.25 | 464.92 | 199.20 |
| High | 0.2452 | 339.17 | 84.46 | 465.75 | 199.20 |
| Low | 0.1889 | 333.49 | 83.48 | 459.39 | 195.82 |
| Last | 0.2156 | 333.72 | 83.79 | 459.65 | 196.32 |
| Change | +0.0256 | -3.66 | -0.15 | -5.27 | -3.04 |
| % Change | +13.47% | -1.08% | -0.18% | -1.13% | -1.52% |
| Volume | 33,900 | 470,146 | 2,117,991 | 342,646 | 424,659 |
| 20-Day Average Volume | 41,625 | 1,788,849 | 7,398,611 | 1,008,252 | 944,703 |
| Previous Close | 0.1900 | 337.38 | 83.94 | 464.92 | 199.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2805 | 330.51 | 80.83 | 478.13 | 200.95 |
| 20-Day Raw Stochastic | 40.74% | 76.65% | 86.78% | 3.73% | 26.16% |
| 20-Day Relative Strength | 34.47% | 55.67% | 71.03% | 41.82% | 39.54% |
| Weighted Alpha | +1.76 | +25.60 | +17.84 | +27.25 | -24.09 |
| Today's Opinion | 56% Sell | 100% Buy | 88% Buy | 24% Buy | 100% Sell |
| Previous Opinion | 56% Sell | 100% Buy | 88% Buy | 24% Buy | 100% Sell |
| Last Month's Opinion | 8% Sell | 72% Buy | 72% Buy | 56% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +86.99% since 04/01/24 | -0.24% since 09/16/24 | +0.73% since 09/16/24 | -5.70% since 09/16/24 | -1.78% since 09/16/24 |
| Low | 0.1113 on 04/02/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 460.02 on 09/23/24 | 195.82 on 09/23/24 |
| High | 0.2452 on 04/08/24 | 339.17 on 09/23/24 | 84.65 on 09/19/24 | 487.23 on 09/17/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | -36.00% since 03/08/24 | +1.72% since 08/23/24 | +9.19% since 08/23/24 | -4.10% since 08/23/24 | -4.38% since 08/23/24 |
| Low | 0.1113 on 04/02/24 | 319.00 on 09/06/24 | 76.42 on 08/26/24 | 460.02 on 09/23/24 | 192.25 on 09/13/24 |
| High | 0.3582 on 03/13/24 | 339.17 on 09/23/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 206.70 on 09/03/24 |
| 3-Month | |||||
| %Chg | -74.24% since 01/08/24 | +8.53% since 06/21/24 | +18.54% since 06/21/24 | -1.53% since 06/21/24 | -12.49% since 06/21/24 |
| Low | 0.1113 on 04/02/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 0.8122 on 01/09/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -35.64% since 10/04/23 | +21.11% since 03/22/24 | +15.37% since 03/22/24 | +11.03% since 03/22/24 | -10.12% since 03/22/24 |
| Low | 0.1113 on 04/02/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.8855 on 11/09/23 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,423 | 180,982,432 | 104,576,912 | 119,974,008 | 29,026,218 |
| Shares Outstanding, K | 52,981 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -14,730,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | -3,090,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 0.51 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/14/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 07/04/24 | 10/29/24 | 11/05/24 | 11/04/24 | 11/13/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.06 | 17.85 | 0.00 | 12.39 |